COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,390 Articles (22,816 medRxiv, 8,574 bioRxiv)

Most recent first Previous |  Page 1593: Articles 15921-15930  | Next

Long-lasting humoral immunity in Covid-19 infected patients at a University Hospital Clinic in Ostergotland County Council during 2020-2021.
Hinkula, J., Azharuddin, M., Aili, D., Naeimipour, S., Selegard, R., Sunnerhagen, M., Patra, H. K., Sjoberg, S. K., Niward, K., Hanberger, H., Ostholm-Balked, A.
10.1101/2021.04.27.441589 — Posted: 2021-04-27
Relative Mutant N501Y SARS-CoV-2 Spike Protein RBD Inhibition of Anti-Spike Protein IgG and ACE-2 Binding to Spike Protein Species
Klegerman, M. E., Cirillo, J. D., McPherson, D. D.
10.1101/2021.04.26.441517 — Posted: 2021-04-27
Mechanical control of innate immune responses against viral infection revealed in a human Lung Alveolus Chip
Bai, H., Si, L., Jiang, A., Belgur, C., Plebani, R., Oh, C. Y., Rodas, M., Nurani, A., Gilpin, S. E., Powers, R. K., Goyal, G., Prantil-Baun, R., Ingber, D. E.
10.1101/2021.04.26.441498 — Posted: 2021-04-27
The Barrier to Vaccination Is Not Vaccine Hesitancy: Patterns of COVID-19 Vaccine Acceptance over the Course of the Pandemic in 23 Countries
Kothari, A., Pfuhl, G., Schieferdecker, D., Harris, C. T., Tidwell, C., Fitzpatrick, K. M., Godleski, S., Sanjay, S.
10.1101/2021.04.23.21253857 — Posted: 2021-04-27
Effects of B.1.1.7 and B.1.351 on COVID-19 dynamics. A campus reopening study
Linka, K., Peirlinck, M., Schafer, A., Tikenogullari, O. Z., Goriely, A., Kuhl, E.
10.1101/2021.04.22.21255954 — Posted: 2021-04-27
VGsim: scalable viral genealogy simulator for global pandemic
Shchur, V., Spirin, V., Pokrovskii, V., Burovski, E., De Maio, N., Corbett-Detig, R.
10.1101/2021.04.21.21255891 — Posted: 2021-04-27
Reliability of COVID-19 data: An evaluation and reflection
Miller, A. R., Charepoo, S., Yan, E., Frost, R. W., Sturgeon, Z. J., Gibbon, G., Balius, P. N., Thomas, C. S., Schmitt, M. A., Sass, D. A., Walters, J. B., Flood, T. L., Schmitt, T. A.
10.1101/2021.04.25.21256069 — Posted: 2021-04-27
Approximate Reciprocal Relationship Between Two Cause-Specific Hazard Ratios in COVID-19 Data With Mutually Exclusive Events
Cetin, S., Ulgen, A., Li, W., Sivgin, H.
10.1101/2021.04.22.21255955 — Posted: 2021-04-27
Predicting daily COVID-19 case rates from SARS-CoV-2 RNA concentrations across a diversity of wastewater catchments
Zulli, A., Pan, A., Bart, S. M., Crawford, F. W., Kaplan, E. H., Cartter, M., Ko, A., Cozens, D., Sanchez, M., Brackney, D. E., Peccia, J.
10.1101/2021.04.27.21256140 — Posted: 2021-04-27
Evaluation of Different Types of Face Masks to Limit the Spread of SARS CoV 2, A Modeling Study
Gurbaxani, B. M., Hill, A. N., Paul, P., Prasad, P. V., Slayton, R. B.
10.1101/2021.04.21.21255889 — Posted: 2021-04-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).